Sage Therapeutics (SAGE) Q2 2025 Earnings

29AprConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.7
-1.46
-1.23
-0.99

Details

Expected EPS
-0.994799
Actual EPS
-1.01
Surprise EPS
-0.02
Surprise Percent
+1.53%

Description

Sage Therapeutics (SAGE) has reported earnings of -1.01 per share for Q2 2025.

0 Comments

Share your thoughts